CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
We have now added a new section called the "Assay History List" to the "At A Gla...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...